B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

IMPDH1

MOLECULAR TARGET

inosine monophosphate dehydrogenase 1

UniProt: P20839NCBI Gene: 36142 compounds

IMPDH1 (inosine monophosphate dehydrogenase 1) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting IMPDH1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of2.7114
2Inosine Monophosphate Inosine 5'-Monophosphate.0.691

About IMPDH1 as a Drug Target

IMPDH1 (inosine monophosphate dehydrogenase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented IMPDH1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

IMPDH1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.